目的:建立一种快速、高效、可视化的细菌多黏菌素耐药基因mcr-1检测方法,为其基层检测的展开提供依据和便利。方法:利用重组酶聚合酶扩增结合胶体金侧向流试纸条技术(Recombinase polymerase amplification combined with a lateral flo...目的:建立一种快速、高效、可视化的细菌多黏菌素耐药基因mcr-1检测方法,为其基层检测的展开提供依据和便利。方法:利用重组酶聚合酶扩增结合胶体金侧向流试纸条技术(Recombinase polymerase amplification combined with a lateral flow dipstick,RPA-LFD),辅以手持式胶体金读数仪;根据mcr-1基因保守序列设计合成一对特异性RPA引物,通过对反应条件和体系的优化,以及特异性试验、灵敏度试验、模拟食样试验和实际样品试验,成功建立了可视化定量检测细菌多黏菌素耐药基因mcr-1的RPA-LFD方法。结果:在引物浓度400 nmol/L,引物比例1:1时,该方法最佳反应条件为Mg^(2+)浓度14.0 mmol/L,反应温度37℃,反应时间20 min;灵敏度好,标准曲线方程为y=0.117x+0.051,定量限为10^(1)~108 copies/μL,检出限为10^(1)copies/μL,比PCR法低一个数量级且模拟样品检出结果与PCR法一致。利用建立的RPA-LFD法对猪肉样品、鸡肉样品、生猪养殖场环境样品、肉鸡养殖场环境样品、大肠杆菌分离株和弯曲肠杆菌分离株各15份中多黏菌素耐药基因mcr-1携带情况进行分析;RPA-LFD法与常规PCR法阳性样本检出率一致,共检出9份mcr-1基因阳性样品。RPA-LFD定量分析显示,阳性样品中mcr-1基因浓度在4.5×10^(2)~8.6×10^(4)copies/μL之间。结论:本研究建立的细菌多黏菌素耐药基因mcr-1的RPA-LFD检测法特异性强、灵敏性高、操作简单,可广泛应用于基层检验。展开更多
BACKGROUND The aim of this study was to investigate the complex heterozygous mutations of ANK1 and SPTA1 in the same individual and improve our understanding of hereditary spherocytosis(HS)in children.We also hope to ...BACKGROUND The aim of this study was to investigate the complex heterozygous mutations of ANK1 and SPTA1 in the same individual and improve our understanding of hereditary spherocytosis(HS)in children.We also hope to promote the application of gene detection technology in children with HS,with the goals of identifying more related gene mutations,supporting the acquisition of improved molecular genetic information to further reveal the pathogenesis of HS in children,and providing important guidance for the diagnosis,treatment,and prevention of HS in children.CASE SUMMARY A 1-year and 5-month-old patient presented jaundice during the neonatal period,mild anemia 8 months later,splenic enlargement at 1 year and 5 months,and brittle red blood cell permeability.Genetic testing was performed on the patient,their parents,and sister.Swiss Model software was used to predict the protein structure of complex heterozygous mutations in ANK1 and SPTA1.Genetic testing revealed that the patient harbored a new mutation in the ANK1 gene from the father and a mutation in the SPTA1 gene from the mother.Combined with the clinical symptoms of the children,it is suggested that the newly discovered complex heterozygous mutations of ANK1 and SPTA1 may be the cause,providing important guidance for revealing the pathogenesis,diagnosis,treatment,and promotion of gene detection technology in children with HS.CONCLUSION This case involves an unreported complex heterozygous mutation of ANK1 and SPTA1,which provides a reference for exploring HS.展开更多
文摘为了解广西地区腹泻仔猪中哺乳动物呼肠孤病毒(MRV)的感染情况及主要流行毒株,应用套式RT-PCR对广西部分地区2020-2022年173份腹泻猪样品进行检测,并选取部分阳性样品进行S 1基因扩增与分析,进一步了解广西地区MRV主要流行毒株的基因特征。结果显示,2020-2022年173份样品MR总阳性率为18%(32/173),各年阳性率分别为29.6%、9.9%和33%。获得1株S 1基因全长序列,序列比对结果发现该序列与其他MRV S 1基因序列的核苷酸同源性为43.4%~97.9%,氨基酸同源性为26.1%~97.8%;遗传进化分析显示,获得的毒株序列为MRV3型,与其他猪源MRV3型毒株ZJ2013、IND/MZ/3013789/reo在同一分支上,同属于谱系Ⅳ。结果表明广西地区猪群存在一定程度的MRV感染,为进一步防控广西腹泻猪群中MRV的流行提供科学依据。
基金Supported by The Science and Technology Department of Sichuan Province,No.2021JDKP0015.
文摘BACKGROUND The aim of this study was to investigate the complex heterozygous mutations of ANK1 and SPTA1 in the same individual and improve our understanding of hereditary spherocytosis(HS)in children.We also hope to promote the application of gene detection technology in children with HS,with the goals of identifying more related gene mutations,supporting the acquisition of improved molecular genetic information to further reveal the pathogenesis of HS in children,and providing important guidance for the diagnosis,treatment,and prevention of HS in children.CASE SUMMARY A 1-year and 5-month-old patient presented jaundice during the neonatal period,mild anemia 8 months later,splenic enlargement at 1 year and 5 months,and brittle red blood cell permeability.Genetic testing was performed on the patient,their parents,and sister.Swiss Model software was used to predict the protein structure of complex heterozygous mutations in ANK1 and SPTA1.Genetic testing revealed that the patient harbored a new mutation in the ANK1 gene from the father and a mutation in the SPTA1 gene from the mother.Combined with the clinical symptoms of the children,it is suggested that the newly discovered complex heterozygous mutations of ANK1 and SPTA1 may be the cause,providing important guidance for revealing the pathogenesis,diagnosis,treatment,and promotion of gene detection technology in children with HS.CONCLUSION This case involves an unreported complex heterozygous mutation of ANK1 and SPTA1,which provides a reference for exploring HS.
